Neuro-Ophthalmology News

Identifying asymptomatic optic nerve lesions in clinically isolated syndrome requires a lower intereye retinal thickness difference threshold than previously reported, according to findings published in Neurology.

Optical coherence tomography angiography can play “a pivotal role” in managing neurodegenerative disorders, though larger studies are needed to optimize its use for this purpose, according to findings published in Eye and Brain.

The FDA has approved Enspryng for adults with anti-aquaporin-4 antibody positive neuromyelitis optica spectrum disorder, according to a Genentech press release.

Japan’s Ministry of Health, Labour and Welfare approved Enspryng to treat adults and children with neuromyelitis optica spectrum disorder, according to a press release.

Viela Bio has received FDA approval for Uplizna, an intravenous treatment for neuromyelitis optica spectrum disorder in certain adults.

Defining objective criteria for glaucomatous optic neuropathy, rather than relying on clinical assessments alone, is needed for comparing outcomes across clinical research studies, according to a speaker at the virtual Association for Research in Vision and Ophthalmology meeting.

Patients treated with satralizumab as monotherapy were at less risk for neuromyelitis optica spectrum disorder relapse compared with patients treated with placebo, according to a study.

by Michael Steiner, PT, DPT

People with Parkinson’s disease have a higher prevalence of ophthalmologic symptoms than those without the disease, according to research published in Neurology, the medical journal of the American Academy of Neurology.

Neuro-ophthalmologic function is affected by subconcussive head impacts which may affect individuals participating in contact sports, according to a randomized clinical trial.